Edit - Forty Seven, which was purchased by GILD today for $95.50/share was trading 3 months ago close to $9/share. And IMO, their drug isn't anywhere near Leronlimab in the number of indications it could possibly treat. Yet, here we are, steamrolling along at $1.05. Time the WORLD knows about CYDY!
NP certainly seems excited and confident. I wish I was that
Edit - Forty Seven, which was purchased by GILD today for $95.50/share was trading 3 months ago close to $9/share. And IMO, their drug isn't anywhere near Leronlimab in the number of indications it could possibly treat. Yet, here we are, steamrolling along at $1.05. Time the WORLD knows about CYDY!
Top 10 Most Recent News Articles
FirstService Unveils New LA Luxury Living Insights
Fresh Insights from Los Angeles' Vertical Living Scene FirstService Residential is throwing the spotlight on luxury high-rises in Los Angeles with their latest episode of Skyline Sessions. Catching wind of this release feels like getting the inside scoop from the horse's mouth—it's about the finer points shaping posh city living in a bustling Californian metropolis....
Continue Reading
Cousins Lobster Hits Arkansas for Tasty Pop-Up Tour
A New England Delicacy Rolling into Arkansas Folks in Northwest Arkansas are about to get a bite of the coast, and it's a big deal for any foodie out there who craves that authentic, no-frills lobster experience. Cousins Maine Lobster is setting out on a pop-up tour—a whirlwind of five days from November 11-15—bringing their joy-inducing lobster rolls straight from...
Continue Reading
Buyers Edge Appoints Sam Peterson as CTO to Lead AI Shift
Anticipating a New Era of AI with Buyers Edge The rumble through the procurement world was more of a jolt this week as Buyers Edge Platform (BEP) threw a new player into the tech gauntlet. Sam Peterson has been handed the reins as the Chief Technology Officer. The goal? To supercharge BEP's innovation engine with some AI-driven gusto. What's in the Cards for Buyers Edge...
Continue Reading
GAC All-New E8 Debuts at 2026 Macao Auto Expo
Revving Up at the Macao Auto Expo Sometimes it feels like the car game’s all about who can shout louder with a new model line-up. And there, under the bright lights of the Venetian Macao Cotai Expo, GAC rolled out their ALL-NEW E8. This wasn’t just another car in their roster; it's the symbol of their steady climb up the ranks and a nod to their decade-long presence...
Continue Reading
Radiofrequency Microneedling: A Fresh Skin Solution?
Vet the Process Before Diving In Everyone wants to turn back the clock on their skin, but it's crucial to know what you're getting into. This ain't a quick splash of water on the face; it's radiofrequency microneedling we're talking about. And honey, it’s no fairy tale—it’s science, plain and simple. Drilling Down on Microneedling This procedure, preached by Dr....
Continue Reading
AstroRad Vest Makes Spaceflight History at Smithsonian
Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...
Continue Reading
Stora Enso Charts Ambitious Path with Demerger Plan
Setting the Stage for Strategic Shifts Alright, folks, Stora Enso, that old behemoth of the paper and forest game, is at it again, shaking things up in a way only veterans of the industry can. They're no strangers to the cutthroat nature of this business, and it looks like they're ready to roll the dice for a new chapter. Amid an inflation-induced rollercoaster where...
Continue Reading
Sentral Expands: Fort Lauderdale & San Diego Additions
Sentral's Strategic Leap into New Markets Ever heard of a company spreading its wings like wildfire? That’s Sentral for you, crashing into Fort Lauderdale and pushing deeper roots in San Diego. We’re not talking minor plays here—these two fresh additions make Sentral a resident-giant stretched across 22 markets. Seems like they’re on a mission to ink their mark...
Continue Reading
Membrane Chromatography Market Surges with Biologics Boom
Another Chapter in Chromatography: What's New? It's like this: membrane chromatography is getting its day in the sun, and it's about time we dive into why it's happening. Projected to scale up from $0.37 billion in 2026 to a neat $0.63 billion by 2031, we’re talking a solid 11.3% compound annual growth rate. It's a tale of tech advancements and rising demand for...
Continue Reading
Systemair Shakes Things Up: Closing Netherlands Facility
Systemair's Shocking Shutdown Decision Feels like we're strapped into a roller coaster with these HVAC companies lately. Systemair (NASDAQ Stockholm: SYSR) sure gave us quite the surprise ride by announcing they're pulling the plug on their production facility in Waalwijk, the Netherlands. This isn't just a ripple in a pond; it's a splash that might make some waves in the...
Continue ReadingTop 5 Most Recently Viewed Articles
Understanding Apollo Commercial Real Estate's Dividend Changes
Apollo Commercial Real Estate Finance's Recent Dividend Change Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) has made headlines recently because of a significant shift in its dividend policy. The company has announced a 29% cut in its dividend payout, raising concerns and questions among investors about the reasons behind this move and what it means for the...
Continue Reading
DaVinci Roofscapes Announces 2024 Project Award Winners
DaVinci Roofscapes Reveals Award-Winning Projects for 2024 LENEXA, Kan. – DaVinci Roofscapes has proudly announced the winners of the esteemed 2024 Masterpiece Contractor Project of the Year Awards. This annual recognition celebrates outstanding contributions from contractors in the roofing industry across residential and commercial segments. Five remarkable residential...
Continue Reading
Indaptus Therapeutics Expands Clinical Trials for Decoy20
Indaptus Therapeutics Reports Exciting Progress in Clinical Trials Indaptus Therapeutics, Inc. (Nasdaq: INDP), a leader in clinical-stage biotechnology, is making significant advancements in developing innovative treatments for cancer and viral infections. Their latest updates highlight important progress in the Decoy20 clinical program, which focuses on increasing...
Continue Reading
New Oriental Plans Shareholders Meeting for Future Engagements
New Oriental Sets Stage for Annual General Meeting New Oriental Education & Technology Group Inc. (NYSE: EDU) recently announced that it is preparing for its annual general meeting of shareholders. This event is a great opportunity for shareholders to engage with the company's management team and discuss future directions for the organization. Meeting Details and...
Continue Reading
Understanding the Retirement Struggles of Generation X
Generation X, those born between 1965 and 1980, stands on the edge of retirement with a shaky footing. Unlike baby boomers who enjoyed workplace pensions, Gen X had to deal with the decline of such safety nets as they entered their careers. Instead, they’ve mostly relied on 401(k) plans—a shift that hasn’t exactly panned out well for many. The Grim Financial...
Continue Reading